Schonfeld Strategic Advisors LLC Cytokinetics Inc Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
Call Options
3 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$806 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$628 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$447 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$413 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$360 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.17B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...